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Abstract
Family  health  history  reflects  the  effects  of  genetic, 
environmental, and behavioral factors and is an impor-
tant  risk  factor  for  a  variety  of  disorders  including 
coronary heart disease, cancer, and diabetes. In 2004, the 
Centers  for  Disease  Control  and  Prevention  developed 
Family  Healthware,  a  new  interactive,  Web-based  tool 
that assesses familial risk for 6 diseases (coronary heart 
disease, stroke, diabetes, and colorectal, breast, and ovari-
an cancer) and provides a “prevention plan” with personal-
ized recommendations for lifestyle changes and screening. 
The tool collects data on health behaviors, screening tests, 
and disease history of a person’s first- and second-degree 
relatives. Algorithms in the software analyze the family 
history data and assess familial risk based on the number 
of relatives affected, their age at disease onset, their sex, 
how closely related the relatives are to each other and to 
the user, and the combinations of diseases in the family. 
A second set of algorithms uses the data on familial risk 
level, health behaviors, and screening to generate person-
alized prevention messages. Qualitative and quantitative 
formative research on lay understanding of family history 
and genetics helped shape the tool’s content, labels, and 
messages. Lab-based usability testing helped refine mes-
sages and tool navigation. The tool is being evaluated by 
3 academic centers by using a network of primary care 
practices  to  determine  whether  personalized  prevention 
messages tailored to familial risk will motivate people at 
risk to change their lifestyles or screening behaviors.
Introduction
In 2002, the Centers for Disease Control and Prevention 
(CDC)  launched  a  public  health  initiative  to  evaluate 
the use of family history information for assessing risk 
for  common  diseases  and  influencing  early  detection 
and  prevention  strategies  (1).  A  multidisciplinary  work 
group reviewed the evidence for family history as a risk 
factor for common diseases (2-9), assessed existing tools 
for  gathering  and  interpreting  family  history  data,  and 
recommended  the  development  of  a  new  family  history 
tool. We describe the development of Family Healthware, 
including the need for the tool, underlying design prin-
ciples, tool components, familial risk stratification, forma-
tive research, and the evaluation plan for determining the 
tool’s validity and utility.
Family history and health
Family history is a significant and prevalent risk fac-
tor for many common diseases, and for most diseases, it 
is  reported  with  a  high  degree  of  accuracy.  (The  Table 
reviews associated risk, prevalence, and accuracy of self-
reports  of  family  history).  For  the  common  chronic  dis-
eases that are typically multifactorial in nature (and only 
rarely  genetically  inherited),  family  history  of  disease 
reflects the effects of genetic and nongenetic risk factors 
(eg,  exposures,  behaviors,  cultural  factors)  shared  by 
affected family members.
Knowledge of the family history can guide risk-specific 
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recommendations for disease management and prevention, 
including referral to a specialist for evaluation and possi-
ble testing. For people suspected of having rare Mendelian 
disorders, recognizing personal and family history charac-
teristics is crucial for determining which patients should 
be offered genetic testing. Prevention strategies for people 
with  increased  familial  risk  of  common  diseases  could 
include lifestyle changes; screening at earlier ages, more 
frequently, and using more intensive methods than those 
used for average-risk individuals; use of chemoprevention; 
and for those at highest risk, prophylactic procedures and 
surgeries. Data about effectiveness of these strategies for 
high-risk individuals are accumulating (31,32).
Tools for gathering and interpreting family history
Americans are not in the habit of collecting and docu-
menting  their  family  health  history,  although  a  survey 
found  that  96%  considered  knowledge  of  family  history 
important to their personal health (33). Physicians also 
perform  poorly  with  respect  to  collecting  family  health 
history from their patients and in interpreting and using 
family  history  to  recommend  risk-specific  interventions 
(34-37). Clinicians may neglect family history because of 
the amount of time required to collect the information and 
possible lack of compensation for these efforts, as well as 
concerns about their ability to interpret such information 
and accurately counsel patients about their risk (38,39).
These barriers could be largely overcome through use of 
electronic family history tools that can 1) collect relevant 
personal and family health history in a structured, codi-
fied format; 2) organize the data into a usable form such 
as  a  graphic  display;  3)  interpret  the  familial  risk  and 
recognize patterns of disease suggestive of inherited sus-
ceptibilities; 4) provide input to overall risk assessment; 
and 5) recommend interventions tailored to the familial 
risk and personal factors. The tools and methods available 
for gathering and interpreting family histories are lacking 
many of these capabilities. Of the available family history 
tools designed to interpret familial risk, most have been 
developed  for  cancer,  particularly  breast  and  colorectal 
cancer (40,41). Generally, these familial risk assessment 
tools are clinical scoring methods, or they use clinical cri-
teria to define the familial risk level. A limitation of these 
methods is that it may be impossible to classify individu-
als whose family histories do not fit the criteria, which is 
problematic for a tool designed for the public or one that 
provides clinical decision support.
Methods
Family Healthware was developed to address the needs 
of health professionals who value accurate family history 
information  for  risk  assessment  but  have  limited  time 
and resources for collecting and interpreting that infor-
mation, and the public who believe their family history 
is important but for the most part do not actively gather 
and  record  that  information.  The  design  and  content 
of  Family  Healthware  were  specified  by  the  multidisci-
plinary work group, and the software was developed by a 
major commercial communications firm with support from 
a software development company. The tool automates the 
process of assessing family history risk and personalizing 
disease prevention strategies, and it provides educational 
resources for health professionals and consumers.
Design principles
The work group reviewed family history tools that were 
being used or developed, and identified tool characteristics 
that enable use for risk assessment and disease preven-
tion, as well as those that make the tools cumbersome 
or  impractical  for  use  by  the  public  and  health  profes-
sionals. From this assessment, we specified several key 
design principles for a new family history tool that focused 
on health promotion and prevention of common chronic   
diseases:
• Self-administered
• Flexible and adaptable to different settings (eg, stand-
alone tools for the consumer, integrated within electron-
ic medical record or public health surveillance systems)
• Simple, easy to use, and designed to collect relevant data 
for familial risk assessment
• Interpretation of familial risk is based on algorithms
• Evidence-based prevention strategies recommended are 
appropriate for the familial risk
A  critical  first  step  in  developing  Family  Healthware 
was to decide which diseases to include. Criteria that could 
be used to guide the selection of diseases (1) were adapted 
and augmented from screening criteria first established by 
the World Health Organization (42) and later updated by, 
among others, the Council of Europe (43): 
• The disease poses a substantial public health burden.
• A well-defined case definition is available.
• Relatives have a high awareness of disease status.VOLUME 6: NO. 1
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• The disease is accurately reported by relatives.
• Family history is an established risk factor.
• Effective interventions exist for primary and secondary 
disease prevention and are specific to the familial risk.
A list of diseases was compiled from tools being used in 
primary care. We applied the inclusion criteria to a list of 
nearly 50 diseases; 15 met many of the criteria (coronary 
heart  disease  [CHD],  sudden  unexpected  death,  stroke, 
hypertension, diabetes, blood clots in lungs or legs, emphy-
sema/lung disease, kidney disease, breast cancer, ovarian 
cancer,  prostate  cancer,  colorectal  cancer,  endometrial 
cancer, thyroid cancer, and kidney cancer). However, very 
few met all of the criteria. For example, cancers of the 
female  pelvic  organs  such  as  endometrial  and  ovarian 
tend to be inaccurately reported by relatives (9); however, 
ascertaining a family history of these cancers is important 
for recognizing hereditary nonpolyposis colorectal cancer 
and  hereditary  breast  and  ovarian  cancer,  respectively. 
The  last  criterion,  “effective  interventions  exist  for  pri-
mary and secondary disease prevention and are specific 
to the familial risk,” presented the greatest challenge for 
most diseases. However, as data accumulate on the valid-
ity and utility of using family history as a screening tool, 
the availability of risk-specific interventions may change. 
The current version of Family Healthware includes 6 dis-
eases — CHD, stroke, diabetes, and breast, ovarian, and 
colorectal cancer. The work group decided that the number 
of diseases should be limited in the first version of the tool 
to facilitate its testing and evaluation in different popula-
tion-based settings.
Algorithms that interpret familial risk
The familial risk stratification (FRS) method integrated 
within Family Healthware is based on a framework that 
represents  the  elements  of  a  pedigree  including  at  a 
minimum the index case and the first- and second-degree 
relatives. In this framework, absence (no or don’t know 
responses)  or  presence  of  a  disease  and  age  of  disease 
onset are considered for every combination of personal and 
family medical history and are assigned a weak, moderate, 
or strong value according to rules derived from empirical 
data. When such data are unavailable, general principles 
of familial risk assessment are followed (44). Rules regard-
ing lineage (ie, maternal, paternal, or nuclear) of affected 
family members are also applied, thus allowing for rec-
ognition of hereditary syndromes that follow Mendelian 
modes of inheritance (eg, autosomal dominant, autosomal 
recessive, X-linked, mitochondrial). Usually, a weak famil-
ial risk is assigned if there is no family history or if there is 
late-onset disease in only 1 second-degree or more distant 
relative from 1 or different sides of the family. Moderate 
familial risk is generally assigned if there is only 1 first-
degree relative with late-onset disease or 2 second-degree 
relatives from the same lineage with late-onset disease. 
Strong familial risk is generally assigned if there is a first-
degree  relative  with  early-onset  disease,  when  multiple 
relatives are affected, or when a hereditary syndrome is 
suspected. For most common chronic diseases, a moderate 
familial risk is associated with about a 2-fold increase in 
risk over a weak familial risk, and a strong familial risk is 
associated with about a 3-fold or greater increase (44).
Evidence-based prevention messages
In the early phases of design, the work group specified 
that  Family  Healthware  should  collect  only  family  his-
tory  information.  A  report  generated  by  the  tool  would 
describe the level of risk for each disease and include gen-
eral messages about health behaviors and screening tests 
to prevent the disease or detect it early. A review of the 
literature suggested, however, that prevention recommen-
dations tailored to patients’ level of disease risk was asso-
ciated  with  increased  screening  for  higher-risk  patients 
(45,46), though evidence to suggest that tailored messages 
influenced health behaviors was limited (47). The work 
group decided that the tool would be more valuable if the 
health behavior and screening messages could be tailored 
not only to family history but also to the user’s lifestyle 
and health habits. Therefore, in addition to collecting fam-
ily history information, the tool was designed to collect 
information  about  health  behaviors  and  screening  tests 
relevant to the 6 diseases. A second set of algorithms was 
added to assign prevention messages based on the familial 
risk level, answers to questions about screening tests and 
health behaviors, and sex and age.
Development of the tool interface
We developed the interface for the tool through an itera-
tive process by using a combination of formative research 
techniques. First, we reviewed the concept to make sure 
it  was  consistent  with  scientific  evidence  and  clinical 
practice. Existing family history tools, both paper-based 
and  electronic,  were  assessed  to  identify  best  practices 
and data collection gaps. Next, we tested several design 
aspects of the tool with a series of consumer focus groups. VOLUME 6: NO. 1
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For example, is it easier for a person to focus on a specific 
disease and recall affected relatives or to focus on specific 
relatives and recall the diseases they have had? We found 
that,  generally  speaking,  focus  group  participants  were 
familiar with family history and could easily recall com-
pleting  a  written  family  history  during  a  primary  care 
visit.  Few  people,  however,  could  recall  updating  their 
family  history  on  subsequent  visits.  Knowledge  of  rela-
tives’ health history varied greatly; common explanations 
include premature death, distant or estranged relation-
ships, large age differences, confusion over cause of death, 
and little communication over personal health matters.
Most participants supported the idea of a computerized 
family  history  tool,  even  though  their  personal  comfort 
and experience with computers varied. They preferred a 
tool provided by their personal physician or health care 
organization, rather than outside groups or insurance pro-
viders. Perhaps the most significant finding was that the 
focus group participants, like the work group, stressed the 
importance of lifestyle in disease prevention and strongly 
advocated for lifestyle recommendations to be added to the 
tool. We tested potential labels for 3 levels of familial risk 
by using wire frames, or paper drawings of screen layouts, 
with 8 focus groups.
The participants found the information that was pre-
sented relevant, but they wanted even more specific and 
detailed  screening  and  lifestyle  recommendations.  For 
example, they wanted to know which screening tests were 
best for them, why, and how often they should get them. 
Reactions  to  the  lifestyle  messages  were  similar.  Most 
reported familiarity with the messages (eg, eat at least 5 
servings of fruits and vegetables daily, lose weight, quit 
smoking) but again requested more specific and directive 
information (eg, which fruits and vegetables to eat, how 
much weight to lose).
Reactions  to  the  labels  that  described  familial  risk 
were more complicated. First, participants were confused 
about familial risk versus overall risk for a disease. They 
preferred to know their overall risk and wanted the tool 
to  provide  that  assessment.  Many  people  interpreted 
“no familial risk” to mean “no disease risk.” In addition, 
there was some confusion about terms such as average 
and moderate, and using a qualifying term (eg, very) with 
a label such as high caused great concern. As a result of 
our testing, we decided to use “strong,” “moderate,” and 
“weak” paired with “family history” to describe familial 
risk — for example, a “weak family history” for diabetes. 
We  believe  these  labels  are  valid,  represent  a  familiar 
rating system, accurately describe familial risk, and limit 
confusion about the concept of familial risk versus overall 
risk for a disease.
Quality assurance testing
To assess the consistency and logic of the programming 
for the FRS method, we used a process called “harness 
testing,”  whereby  the  FRS  framework  and  accompany-
ing  rules  for  interpreting  the  familial  risk  were  tested 
by computer-generated family history scenarios of every 
possible combination of events. This process was followed 
by an internal expert review that checked for consistency 
between the output of the tool and the written programmed 
directions and by heuristic testing with internal and exter-
nal experts. Experts in computer application design and 
navigation used the tool and advised how best to design 
the various navigational and visual elements of the tool.
Usability testing
An independent research firm conducted usability test-
ing. The Figure is an example of a screen shot from the 
tool, with notations made after the testing process. For 
each of 2 rounds, 8 men and women older than 45 with 
some family history of 1 of the 6 diseases assessed by the 
tool participated in a 1-on-1 usability test conducted in a 
computer laboratory. An experienced interviewer guided 
each person through the application, soliciting feedback 
on key aspects. Questions were designed to generate users’ 
reactions, assessments, difficulties in tool use, and overall 
reactions, which were then documented by the interviewer 
and observers seated behind 1-way mirrors.
The first round of usability testing focused primarily on 
the tool’s navigation and data entry of family history and 
lifestyle and screening behaviors. Participants were gener-
ally positive about the concept of the tool and, for the most 
part, found it easy to use and navigate. Testing identified 
a number of design features that could benefit from minor 
changes  to  minimize  errors  and  misunderstanding.  For 
instance, we repositioned several key data entry points to 
be more prominent on the page. We moved error messages 
closer to the actual error and clarified the wording to facili-
tate correct data entry. We greatly simplified text, as we 
learned that users quickly navigated through the tool and 
tended not to read more than a few instructions or bulleted VOLUME 6: NO. 1
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points.  Users  skimmed 
over  or  ignored  para-
graphs,  and  text  even 
as  short  as  a  few  sen-
tences  was  not  always 
read.  Despite  our  best 
efforts to use standard-
ized and validated ques-
tions  for  screening  and 
lifestyle, we still encoun-
tered  text  we  could 
improve.  For  example, 
our  smoking  question 
asked  about  cigarettes 
but  did  not  include 
cigars. The revised ques-
tion  now  asks,  “Do  you 
smoke  tobacco,  includ-
ing cigarettes, a pipe, or 
cigars?”
After  making  all  of  the  text  changes,  we  retested  the 
enhanced tool by focusing on the results that it generated, 
namely, the familial risk assessment for each disease and 
the lifestyle and screening message content. Users immedi-
ately focused on diseases for which they had a moderate or 
strong familial risk. Although we wanted (and even expect-
ed) users to carefully study their risk assessment for each 
disease, we quickly learned that they were most interested 
in the diseases where increased familial risk was identified. 
We also wanted feedback on how much information about 
health promotion and disease prevention to provide to users; 
thus, we tested 2 types of messages, a long text version of 
screening recommendations and a short bulleted-list ver-
sion for lifestyle changes. Almost all users clearly preferred 
the  short  bulleted  content.  However,  many  participants 
wanted the messages and tool to be more comprehensive. 
For instance, instead of reading “lose weight” they wanted 
to know how much weight to lose. (We later included tables 
of body mass index [BMI] into the software to provide users 
with the ideal weight range for their height.) They also 
wanted the tool to be integrated with aspects of the medi-
cal record and history and to document the user’s blood 
pressure measurements and cholesterol levels. Although 
we could not turn the tool into a comprehensive electronic 
medical record, we could respond to several suggestions. 
To balance information needs and preferences of our users, 
we developed a tiered approach to the messages. The first 
message  that  appeared  on  the  screen  contained  a  sen-
tence or 2, with a click-
able  symbol  to  reveal  a 
more  detailed  message. 
In addition, we heard we 
should  praise  healthy 
lifestyle  choices,  not 
just  focus  on  what  peo-
ple were “doing wrong.” 
Consequently, we added 
messages  reinforcing 
positive behaviors. 
Results
Family  Healthware 
is intended as a screen-
ing  tool  for  population-
wide use; therefore, the 
amount  of  data  that  is 
collected  is  limited  to 
relevant and actionable information. Family Healthware 
does not collect the detailed and extensive family histories 
that genetics professionals need to evaluate people at risk 
for genetic disorders. As a screening tool, however, Family 
Healthware can identify prople with a strong family his-
tory who might require further in-depth risk assessment 
by a specialist or another computerized model, such as 
BRCAPRO,  a  genetic  susceptibility  model  that  predicts 
the likelihood of a BRCA1 or BRCA2 gene mutation (48).
The  data  elements  collected  in  Family  Healthware 
include the following:
• Personal information: name, date of birth, sex, adoption 
status, race/ethnicity, Ashkenazi Jewish heritage, and 
current height and weight, which are used to calculate 
BMI.
• Health behaviors: smoking, physical activity, fruit and 
vegetable consumption, alcohol use, and aspirin use.
• Screening  tests:  blood  cholesterol,  blood  pressure, 
blood  glucose,  fecal  occult  blood  test,  sigmoidoscopy, 
colonoscopy, and, for women, clinical breast exam and   
mammogram.
• Disease  history  of  a  person’s  first-  and  second-degree 
biological  relatives  (parents,  siblings,  children,  grand-
parents, aunts, and uncles) for the 6 diseases included in 
the tool, with age at first diagnosis described by 5-year 
increments.
Figure. Example of a screen shot from Family Healthware usability testing, with 
notations of findings from usability testing.VOLUME 6: NO. 1
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The  report  generated  by  the  tool  includes  a  state-
ment about familial risk and disease-specific lifestyle and 
screening messages that are based on familial risk as well 
as a person’s individual health and screening behaviors. 
For example, a person with a strong familial risk of diabe-
tes who had never had a blood glucose test would receive 
the message, “You may benefit from blood sugar testing 
because of your family history. Talk to your health profes-
sional about your blood sugar and how it affects your risk 
of diabetes.” Likewise, people who indicate that they are 
not  exercising  at  the  level  currently  recommended  (49) 
would receive the message, “Increase your physical activ-
ity.” Each of these short messages is linked to a longer 
explanation of why the behavior or screening test is impor-
tant and what issues the users should discuss with their 
health care professional (Box). The challenge in delivering 
individualized behavioral and screening messages was col-
lecting enough information to determine compliance with 
behavioral and screening recommendations by age, sex, 
and familial risk level — and not burdening the respon-
dent with too many questions. The behaviors and screen-
ing tests included in Family Healthware are those that are 
associated with the 6 diseases in the tool and for which an 
evidence-based guideline exists (50,51).
Validation of Family Healthware
The rules underlying the familial risk assessment and 
pedigree analysis functions of the FRS methods used in 
Family Healthware are derived from empirical data that 
have accumulated in the scientific literature over several 
decades  (44).  Validation  of  the  risk  stratification  rules 
included in Family Healthware has been limited because 
few existing population-based data include all of the fam-
ily history-related data elements and follow-up outcome 
data on the diseases of interest. Determining the clinical 
validity of the FRS rules and adjusting them accordingly 
is a critical component of a research agenda to evaluate 
Family Healthware and the use of family history in pre-
ventive medicine.
Recently, we assessed the performance of risk stratifi-
cation rules similar to those used in Family Healthware 
for  identifying  the  outcomes  of  early-onset  (diagnosed 
before age 60) CHD and type 2 diabetes by using cross- 
sectional survey data from nationally representative sam-
ples  (11,20,52).  With  data  from  the  HealthStyles  2003 
survey, we found that, after adjusting for demographics, 
compared  with  weak  familial  risk,  strong  and  moder-
ate familial risk categories were significantly associated 
with a 4.9-fold (95% confidence interval [CI], 3.3-7.2) and 
2.0-fold  (95%  CI,  1.1-3.6)  increase  in  early-onset  CHD, 
respectively  (11).  Using  the  HealthStyles  2004  survey, 
we found that, compared with respondents with a weak 
familial  risk  for  diabetes,  respondents  with  strong  and 
moderate familial risk had increased self-reports of diabe-
tes (7.6-fold [95% CI, 5.9-9.8] and 3.6-fold [95% CI, 2.8-4.7], 
respectively) after adjusting for demographic factors (52). 
In a more recent analysis of 16,388 adults interviewed for 
the National Health and Nutrition Examination Survey 
during 1999-2004, we found that the odds of having dia-
betes for people in the strong and moderate familial risk 
categories,  compared  with  those  on  the  weak  category, 
were 5.5 (95% CI, 4.4-6.8) and 2.3 (95% CI, 1.8-2.9) times 
higher, respectively (20). These studies support the use 
of a 3-tiered familial risk assessment method to identify 
people at increased risk for selected chronic diseases, but 
true validation of the FRS used in Family Healthware will 
require the assessment of sensitivity, specificity, and pre-
dictive value in large prospective cohorts.
Evaluating  the  usefulness  of  Family  Healthware  will 
require multiple studies in different populations and set-
tings. Even if the risk assessment is valid and useful for 
Get your cholesterol tested. Talk to your health profes-
sional about your family history, how it affects your risk 
of coronary heart disease or stroke, and your options 
for screening and prevention.
Your cholesterol testing should include a measure of 
your total cholesterol, low-density lipoprotein (the “bad” 
cholesterol), high-density lipoprotein (the “good” cho-
lesterol), and triglycerides. If your cholesterol levels are 
high or abnormal, changing your lifestyle and/or taking 
medication can reduce your risk of coronary heart dis-
ease and stroke. Because of your increased risk, you 
may need to test for other cardiovascular risk factors. 
Ask your health professional how often you should test 
your cholesterol. The frequency of testing will depend 
on your cholesterol levels, other risk factors, and if you 
already are being treated for cholesterol problems.
Box. Screening message for an adult with moderate or strong famil-
ial risk of coronary heart disease or stroke who has not had a blood 
cholesterol test in the past  years, from Family Healthware com-
puter-based health risk assessment software tool.VOLUME 6: NO. 1
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predicting  who  will  get  disease,  will  the  feedback  and 
prevention messages improve health behavior and screen-
ing? As a first step in answering this question, 3 academic 
research centers — The University of Michigan School of 
Medicine,  Evanston  Northwestern  Healthcare  Research 
Institute, and Case Western Reserve University School of 
Medicine — are collaborating on a study set in primary 
care practices to examine the effect of Family Healthware 
on risk perceptions, disease-related attitudes and beliefs, 
and change in health behaviors. Results from this study 
are forthcoming and may shed light on the use of Family 
Healthware in a real-world setting and the effect of famil-
ial risk notification on attitudes about disease and motiva-
tion to change behaviors.
One goal of the initiative was to identify effective family 
history tools and strategies that could be used to identify 
people at increased risk for chronic diseases and influence 
their  health  behaviors  and  use  of  preventive  services. 
Even though more work needs to be done to validate the 
risk algorithms, early studies (11,20,52) demonstrate the 
clinical validity of a 3-tiered familial risk gradient from 
weak to moderate to strong. The area in greatest need of 
study is whether familial risk assessment might influence 
health behaviors and use of preventive services. We hope 
that  further  research  and  evaluation  will  provide  sup-
port for the use of new and innovative tools as part of an 
overall strategy to reduce common chronic diseases in the 
population.
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Table
Table. Selected Studies Describing the Risk Association, Prevalence, and Accuracy of Self-Reports for Family History and the 
6 Diseases Evaluated in Family Healthware
Disease
Disease Risk Associated With Family 
History
Prevalence of Family History of 
Disease Accuracy of Reported Family History
Coronary heart 
disease (CHD)
• Risk of cardiovascular disease (CVD) asso-
ciated with sibling CVD (OR = 2.0) and 
parental CVD (OR = 1.)10
• 1% of Utah families with a family history 
of CHD accounted for 72% of early-onset 
(at age < y) CHD cases2
• Approximately 0% of respondents 
to a national survey had a first- or 
second-degree relative with CHD11
• 1% of women aged  or older 
had parental history of myocardial 
infarction12
• Comparing study participant’s report with 
relatives’ report yielded 79% sensitivity 
and 91% specificity1
• Comparing study participant’s report with 
parents’ report yielded 8% sensitivity 
and 9% specificity1
Stroke • Risk of large-vessel stroke associated with 
family history of stroke at age ≤65 y (OR = 
2.2); also, risk of small-vessel disease (OR 
= 1.9)1
• Risk of hemorrhagic stroke in women aged 
18- y associated with family history of 
stroke in a first-degree relative (OR = 2.); 
also, risk of ischemic stroke (OR = 1.8)16
• 26% of study participants (aged 
> y) reported a parental history 
of stroke, and 12% reported sibling 
history of stroke17
• Comparing study participant’s report with 
father’s medical records yielded 2% 
sensitivity and 96% specificity; comparing 
study participant’s report with mother’s 
medical records yielded 1% sensitivity 
and 98% specificity18
Diabetes • Risk of diabetes associated with maternal 
diabetes (OR = .), paternal diabetes (OR 
= .), and both parents with diabetes (OR 
= 6.1)19
• Risk of diabetes associated with strong (OR 
= .) and moderate (OR = 2.) familial 
risk as compared with weak familial risk20
• 1% of adults reported a family 
history of diabetes in a first-degree 
relative21
• 8% of adults reported a family his-
tory of diabetes among first-degree 
relatives or grandparents22
• Comparing study participant’s report with 
parents’ report yielded 87% sensitivity 
and 98% specificity1
• Comparing study participant’s report with 
sibling’s report yielded 72% sensitivity 
and 98% specificity1
Breast cancer • Pooled estimate of RR associated with 
various family histories: any relative (RR 
= 1.9); a first-degree relative (RR = 2.1); 
mother (RR = 2.0); sister (RR = 2.); 
mother and sister (RR = .6); and a sec-
ond-degree relative (RR = 1.)2
• Risk for breast cancer associated with 
increasing numbers of affected first-degree 
relatives: 1 (RR = 1.8); 2 (RR = 2.9); ≥3 
(RR = .9)2
• %-10% of women with breast 
cancer have a mother or sister with 
breast cancer and up to 20% have 
a first- or second-degree relative 
with breast cancer2
• 1% of women with breast cancer 
and 7.3% of controls reported ≥1 
first-degree relatives with a history 
of breast cancer2
• Comparing patient’s report with first-
degree relatives’ medical record or self-
report yielded 9% sensitivity and 97% 
specificity9
• Comparing participant’s report with reg-
istry data for first-degree relatives yielded 
82% sensitivity for controls and 8% 
sensitivity for cases2
Ovarian cancer • Lifetime probability of ovarian cancer 
increases from about 1.6% for a -year-
old woman without a family history of ovar-
ian cancer to about % if she has 1 relative 
with ovarian cancer and 7% if she has 2 
affected relatives26
• Risk of ovarian cancer associated with 
breast cancer in first- or second-degree 
relative (RR = 1.4); also, ≥2 first-degree 
relatives with breast cancer (RR = 1.8)27
• 1.8% of adult respondents to a 
national survey reported having ≥1 
first-degree relative with ovarian 
cancer28
• Comparing patient’s report with first-
degree relatives’ medical record or self-
report yielded 8% sensitivity and 99% 
specificity9
• Comparing participant’s report with reg-
istry data for first-degree relatives yielded 
0% sensitivity for controls and 67% 
sensitivity for cases2
 
Abbreviations: OR, odds ratio; RR, relative risk.
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Disease
Disease Risk Associated With Family 
History
Prevalence of Family History of 
Disease Accuracy of Reported Family History
Colorectal can-
cer (CRC)
• Risk of CRC associated with affected first-
degree relatives (RR= 1.7); also, with ≥2 
affected first-degree relatives (RR = 2.8)29
• Pooled estimates of relative risk for CRC by 
affected relative: a first-degree relative (RR 
= 2.2); parent (RR = 2.26); sibling (RR 
= 2.57); ≥1 relative (RR = 4.25)0
• % of adult respondents to a 
national survey reported having ≥1 
first-degree relative with CRC28
• In a large cohort study of health 
professionals, 9.% of men report-
ed a history of CRC in a parent or 
sibling and 10% of women reported 
the same29
• Comparing patient’s report with first-
degree relatives’ medical record or self-
report yielded 90% sensitivity and 97% 
specificity9
• Comparing participant’s report with reg-
istry data for first-degree relatives yielded 
81% sensitivity for controls and 6% 
sensitivity for cases2
 
Abbreviations: OR, odds ratio; RR, relative risk.
Table. (continued) Selected Studies Describing the Risk Association, Prevalence, and Accuracy of Self-Reports for Family 
History and the 6 Diseases Evaluated in Family Healthware